C$0.04 AIML.CN AI/ML Innovations Inc. (CNQ) 18 Mar 2026: Watch valuation gap

AIML.CN stock trades at C$0.04 on the CNQ as of 18 Mar 2026, reflecting a thinly traded small‑cap in Canadian healthcare focused on AI wearables. Volume today is 68,020.00 shares versus a 50‑day average of 443,246.00, and the company reports EPS of -0.03. Investors should note a mixed signal set: low market cap (C$6,730,560.00), negative margins, and a patent‑pending wearable that keeps speculative upside possible. This report ties the latest metrics to technicals, valuation, Meyka AI grading, and a clear set of price targets and risks.

AIML.CN stock snapshot and market context

AI/ML Innovations Inc. (AIML.CN) is listed on CNQ in Canada and operates in digital healthcare and medical information services. The stock opened at C$0.04, with a day low of C$0.04 and day high of C$0.04 today. Market cap is C$6,730,560.00 and shares outstanding are 168,264,000.00.

The healthcare sector has lagged year to date; sector performance is negative over 1Y and YTD, which pressures small healthcare tech names. AIML.CN’s year high is C$0.12 and year low is C$0.03, underlining high historical volatility for this microcap.

Fundamentals and valuation for AIML.CN stock

Revenue per share TTM is 0.00 and net income per share TTM is -0.03, producing a price to sales ratio near 40.00 and a PB ratio of 5.23. EPS is -0.03 and trailing PE is negative at -1.33, reflecting losses. Current ratio is 2.09, and debt to equity is 0.11, showing a low leverage profile but weak profitability.

These metrics suggest the company remains pre‑commercial or early revenue with high valuation multiples on tiny sales. That combination increases downside risk if product adoption stalls.

Technicals and trading signals for AIML.CN stock

Price averages are thin: 50‑day average is C$0.04 and 200‑day average is C$0.05. RSI sits near 53.32, indicating neutral momentum. On‑balance volume is negative at -538,779.00, and relative volume is 0.15, so trading interest is below average.

Low liquidity and wide gaps between daily ranges increase execution risk for larger orders. Traders should expect slippage and sporadic spikes rather than smooth moves.

Meyka AI rates AIML.CN with a score out of 100 and forecast

Meyka AI rates AIML.CN with a score of 62.24 / 100 and assigns a B: HOLD suggestion. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are informational and are not financial advice.

Meyka AI’s forecast model projects a yearly price of C$0.02 and a monthly level of C$0.02. Compared with the current price of C$0.04, the yearly projection implies an estimated downside of -45.65% and the monthly projection implies -50.00%. Forecasts are model‑based projections and not guarantees. Note: third‑party company rating dated 17 Mar 2026 shows a company rating of C‑ (Strong Sell) driven by DCF and margin scores.

Risks, catalysts and AIML.CN stock opportunities

Primary risks include continued negative margins, low revenue traction, and thin liquidity that amplifies downside. Key ratios show negative operating cash flow per share -0.03 and long receivable days, both red flags for working capital stress.

Potential catalysts are successful commercialization of the patent‑pending wearable, partnership announcements, and improved monthly recurring revenue. Given the year high of C$0.12, upside is possible but heavily conditional on execution and market acceptance.

Outlook, price targets and strategy for AIML.CN stock

We set a three‑scenario price target range: bear C$0.02, base C$0.04, and bull C$0.10. Bear target implies -50.00% downside, base is flat versus the current price, and bull implies +150.00% upside from C$0.04. These targets blend historical volatility, year high, and speculative commercial outcomes.

For position sizing, treat AIML.CN as a high‑risk microcap idea suited for speculative allocation under strict risk limits. Use limit orders, size small, and monitor newsflow and liquidity.

Final Thoughts

AIML.CN stock trades at C$0.04 on CNQ with small market cap and mixed signals from fundamentals and technicals. Meyka AI assigns a 62.24 / 100 (B, HOLD) grade while a third‑party company rating shows C‑ (Strong Sell), reflecting differing weightings for growth potential versus weak margins. Meyka AI’s forecast model projects a yearly price of C$0.02, implying an approximate -45.65% downside to the current price; forecasts are model‑based and not guarantees. Upside to C$0.10 exists if the company proves commercial traction for its wearable and digital health software, but investors must weigh fragile liquidity, negative earnings (EPS -0.03) and thin revenues. In short, AIML.CN is a speculative AI healthcare microcap that may suit only small, well‑diversified allocations and active traders who can manage execution risk. For live updates and screening tools consult AIML.CN on Meyka AI and track official filings and partner announcements.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.